JOSEPH ROYS to Disease-Free Survival
This is a "connection" page, showing publications JOSEPH ROYS has written about Disease-Free Survival.
Connection Strength
0.030
-
Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment. Clin Nucl Med. 2017 Jun; 42(6):436-443.
Score: 0.030